Skip to main content icon/video/no-internet

Harm reduction focuses on reducing the adverse consequences of psychoactive drug use and drug control policies. It is usually thought of having its roots in Dutch drug policy, which takes a public health or sociomedical approach in recognizing and responding to drug use and its consequences. A simplistic conceptualization posits that if users are unable or unwilling to refrain from drug use, then they should be assisted in reducing the harm caused to themselves and others. Harm reduction is pragmatic. It tries to minimize the damage that drug users do to themselves, to other people, and to society at large. Inherent in the conceptual fuzziness of harm reduction is deciding what constitutes harm, who is harmed, and how harms should be prioritized.

Harm-reduction advocates view a “drug-free” society as unachievable, since drug use has been a part of human societies since the dawn of mankind. Therefore, they give greater priority to reducing the harms to the drug user and others, instead of focusing on decreasing drug use itself. Although the official U.S. view tends to equate harm reduction with legalization, most advocates of harm reduction do not support legalization, on the grounds that it would increase drug use. Still, they recognize that prohibition not only does not stop drug use but creates crime and marginalizes drug users. Harm reduction interventions focus on integrating or reintegrating drug users into the community, taking care not to further isolate, demonize, or ostracize them. Priority is placed on maximizing the number of drug users in contact with public health and social services. Drug policies are evaluated in terms of their potential effects on minimizing the harms of drugs to the user and to the larger society.

Harm reduction advocates ask: How can we reduce the likelihood that drug users will engage in criminal and other undesirable activities? How can we reduce the overdoses and cases of HIV/AIDS and hepatitis B and C associated with the use of some drugs? How can we increase the chances that drug users will act responsibly toward others? How can we increase the likelihood of rehabilitation? and more generally, how do we ensure that drug control policies do not cause more harm to users and society than drug use itself?

The Emergence of Harm Reduction

The Dutch instituted their first needle-exchange program in Amsterdam in 1984, in an attempt to stem the rising number of hepatitis cases related to injection drug use (IDU). They decided that hepatitis was a greater evil than IDU and therefore established programs to provide new needles and syringes to injection drug users (IDUs). These programs were in place not long after AIDS was first recognized in 1981, and the connection was made between the spread of HIV/AIDS and IDU. As a result, the AIDS epidemic among Dutch injection drug users has never reached the levels seen in most countries.

Several other European countries, including the United Kingdom and Switzerland, adopted harmreduction policies in response to the AIDS epidemic, stating that AIDS represents a greater threat to public health than does drug use, and that AIDS prevention should take precedence over antidrug efforts. In 1986, the World Health Organization urged that policies aimed at reducing drug use not be allowed to compromise measures to prevent the spread of AIDS. The British Advisory Council on the Misuse of Drugs echoed that sentiment in 1988. In 1986, the Mersey Regional Drug Training and Information Center became one of the first syringe exchange programs in the U.K.—and presumably the world—to make sterile injecting equipment available to users as a way of preventing HIV/AIDS.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading